Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 27, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Is Scar Tissue A Protective Immune Cell?

NIPER-G Recruitment With Rs. 67,000 pm Pay | Online Applications Invited

COVID-19 Diagnosis Using CRISPR Project Recruitment For Life Sciences at NICED

Is Scar Tissue A Protective Immune Cell?
  • BiotechToday
  • World

Is Scar Tissue A Protective Immune Cell?

bioxone March 12, 2021March 12, 2021

Souradip Mallick, National Institute of Technology, Rourkela

 Nowadays abdominal surgery is very common and many patients undergo this operation to remove internal scar tissue. This scar is the accumulation of the macrophage which is a protective immune cell. But there are many postsurgical complications.

Lysis of adhesions destroys the scar tissue resulting in abdominal and chronic pelvic pain. The scar tissue which forms after surgery is simple a healing process but sometimes can also develop after an infection or a condition that causes inflammation, such as endometriosis.

For investigating the role of macrophage abdomen was stretched out to form a bulge like a hernia in the mice model and then the activity of cell was observed through a translucent tissue in the part of the abdomen. Then with a help of a laser, a small burn was induced on the abdominal wall. 

Immediately after that burn, macrophages start to accumulate on the damaged area and interlaced with tough protein fibres and formed a cap to prevent the damaged area from other areas. The more the macrophage accumulates at that place faster the recovery would take place. If any molecule can be induced to prevent the accumulation of the macrophage then the recovery will be slowed down.

Metaphase: The rapid accumulation of macrophages in any damaged or burnt tissue results in fast recovery of the tissue making it a protective immune cell against further damage. 

Also read:Zolgensma: World’s most expensive life-saving drug approved

Source: Mitch Leslie; “These bacteria-gobbling immune cells help the body heal—but also cause surgical complications”; ScienceMag.org; Mar. 4, 2021

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged abdominal surgery chronic pelvic pain endometriosis hernia macrophage

One thought on “Is Scar Tissue A Protective Immune Cell?”

  1. Pingback: Insect Apocalypse!! Butterflies disappearing at an alarming rate - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

COVID-19 Diagnosis Using CRISPR Project Recruitment For Life Sciences at NICED

bioxone March 12, 2021

-Shristi Sharma, Team bioXone NICED Life Science Job – Project Research Associate Vacancy. ICMR-National Institute of Cholera & Enteric Diseases recruiting for Project Research Associate position for MSc/Ph.D. Life Sciences candidates. Research positions for life science candidates at NICED, details given below:  No. 01/CRISPER Based Diagnosis/2020-21 Title of Job: Project Research Associate-I No. of Posts: […]

Related Post

  • BiotechToday
  • World

Nitrogen dioxide reduction leads to an increase in crop yield

BioTech Today July 2, 2022July 2, 2022

Sumedha B S, Bangalore University Increasing the number of crops isn’t the only way to feed a growing population. This research points out that controlling air pollution is vital to increasing crop production. This method saves land and money. Improvements in agricultural productivity are a necessity for the coming decades to achieve sustainable development goals. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Effect of pollution on thyroxine levels in newborns

BioTech Today July 10, 2021July 9, 2021

Esha Mohite, MGM’s College of Engineering and Technology Effect of pollution on baby’s general development: The bond between a mother and her baby is powerful like no other. A baby’s first-ever human contact is with its mother. The mother’s body nourishes its baby and protects it. The placental cord plays a significant role in developing […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • India
  • World

AstraZeneca: Late-stage trial of Covid-19 antibody medicine to start soon

bioxone October 12, 2020October 12, 2020

Prama Ghosh, Amity University Kolkata After the recovery of President Donald Trump from Covid-19 using a similar therapy as of the antibody medicine from AstraZeneca Plc, the company has started its late-stage trials for the same against COVID-19. The medicine will undergo two trials on more than 60000 people starting soon. Astra has also planned […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy